The Gold Rush Intensifies: Record Investment and M&A Activity Propel Cell Therapy Market Toward $29 Billion Horizon
As scientific breakthroughs accelerate, venture capital and strategic acquisitions create a high-stakes battlefield for the next generation of cancer and genetic cures. The cell therapy landscape, once a frontier of speculative science, has erupted into a multi-billion-dollar arena defined by staggering financial bets and high-stakes corporate maneuvers. Fueled by demonstrable clinical success and the promise…